111 related articles for article (PubMed ID: 8789792)
1. The myocardial lesions produced by the potassium channel opener aprikalim in monkeys and rats are prevented by blockade of cardiac beta-adrenoceptors.
Belin V; Hodge T; Picaut P; Jordan R; Algate C; Gosselin S; Nohynek G; Cavero I
Fundam Appl Toxicol; 1996 Jun; 31(2):259-67. PubMed ID: 8789792
[TBL] [Abstract][Full Text] [Related]
2. Protective effects of the K+ ATP channel opener, aprikalim, against free radicals in isolated rabbit hearts.
Pignac J; Lacaille C; Dumont L
Free Radic Biol Med; 1996; 20(3):383-9. PubMed ID: 8720909
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological evidence for a role of ATP-dependent potassium channels in myocardial stunning.
Auchampach JA; Maruyama M; Cavero I; Gross GJ
Circulation; 1992 Jul; 86(1):311-9. PubMed ID: 1301066
[TBL] [Abstract][Full Text] [Related]
4. ATP gated potassium channels in acute myocardial hibernation and reperfusion.
Offstad J; Kirkebøen KA; Ilebekk A; Downing SE
Cardiovasc Res; 1994 Jun; 28(6):872-80. PubMed ID: 7923294
[TBL] [Abstract][Full Text] [Related]
5. Anti-ischaemic actions of potassium channel openers in experimental myocardial ischaemia/reperfusion injury in dogs.
Auchampach JA; Gross GJ
Eur Heart J; 1993 Jul; 14 Suppl B():10-5. PubMed ID: 8370365
[TBL] [Abstract][Full Text] [Related]
6. Effect of subarachnoid hemorrhage on cerebral vasodilatation in response to activation of ATP-sensitive K+ channels in chronically hypertensive rats.
Sobey CG; Heistad DD; Faraci FM
Stroke; 1997 Feb; 28(2):392-6; discussion 396-7. PubMed ID: 9040696
[TBL] [Abstract][Full Text] [Related]
7. Cardioprotective actions of potassium channel openers.
Auchampach JA; Maruyama M; Gross GJ
Eur Heart J; 1994 Aug; 15 Suppl C():89-94. PubMed ID: 7995278
[TBL] [Abstract][Full Text] [Related]
8. Nicorandil: differential contribution of K+ channel opening and guanylate cyclase stimulation to its vasorelaxant effects on various endothelin-1-contracted arterial preparations. Comparison to aprikalim (RP 52891) and nitroglycerin.
Borg C; Mondot S; Mestre M; Cavero I
J Pharmacol Exp Ther; 1991 Nov; 259(2):526-34. PubMed ID: 1682478
[TBL] [Abstract][Full Text] [Related]
9. Effects of P1060 and aprikalim on whole-cell currents in rat portal vein; inhibition by glibenclamide and phentolamine.
Ibbotson T; Edwards G; Noack T; Weston AH
Br J Pharmacol; 1993 Apr; 108(4):991-8. PubMed ID: 8485637
[TBL] [Abstract][Full Text] [Related]
10. Time-dependent fading of the activation of KATP channels, induced by aprikalim and nucleotides, in excised membrane patches from cardiac myocytes.
Thuringer D; Cavero I; Coraboeuf E
Br J Pharmacol; 1995 May; 115(1):117-27. PubMed ID: 7647966
[TBL] [Abstract][Full Text] [Related]
11. Aprikalim reduces the Na+-Ca2+ exchange outward current enhanced by hyperkalemia in rat ventricular myocytes.
Li HY; Wu S; He GW; Wong TM
Ann Thorac Surg; 2002 Apr; 73(4):1253-9; discussion 1259-60. PubMed ID: 11996269
[TBL] [Abstract][Full Text] [Related]
12. Elective cardiac arrest with a hyperpolarizing adenosine triphosphate-sensitive potassium channel opener. A novel form of myocardial protection?
Cohen NM; Wise RM; Wechsler AS; Damiano RJ
J Thorac Cardiovasc Surg; 1993 Aug; 106(2):317-28. PubMed ID: 7848379
[TBL] [Abstract][Full Text] [Related]
13. The new K+ channel opener Aprikalim (RP 52891) reduces experimental infarct size in dogs in the absence of hemodynamic changes.
Auchampach JA; Maruyama M; Cavero I; Gross GJ
J Pharmacol Exp Ther; 1991 Dec; 259(3):961-7. PubMed ID: 1762089
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of vasoconstriction by potassium channel opener aprikalim in human conduit arteries used as bypass grafts.
He GW; Yang CQ
Br J Clin Pharmacol; 1997 Oct; 44(4):353-9. PubMed ID: 9354310
[TBL] [Abstract][Full Text] [Related]
15. Aprikalim a potassium adenosine triphosphate channel opener reduces neurologic injury in a rabbit model of spinal cord ischemia.
Lozos VA; Toumpoulis IK; Agrogiannis G; Giamarellos-Bourboulis EJ; Chamogeorgakis TP; Rizos IK; Patsouris ES; Anagnostopoulos CE; Rokkas CK
Int J Surg; 2013; 11(4):354-9. PubMed ID: 23473993
[TBL] [Abstract][Full Text] [Related]
16. The effects of a newly synthesized ATP-sensitive potassium channel opener, MJ-355, on blood pressure and myocardial ischemia-reperfusion injury in rats.
Lee YM; Peng YY; Sheu JR; Cheng CY; Yen MH
Jpn J Pharmacol; 1999 Oct; 81(2):185-93. PubMed ID: 10591476
[TBL] [Abstract][Full Text] [Related]
17. The antihypertensive and cardioprotective effects of (-)-MJ-451, an ATP-sensitive K(+) channel opener.
Lee YM; Yen MH; Peng YY; Sheu JR; Chen YC; Chang MJ; Cheng CY
Eur J Pharmacol; 2000 May; 397(1):151-60. PubMed ID: 10844109
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effects of protein kinase C on inwardly rectifying K+- and ATP-sensitive K+ channel-mediated responses of the basilar artery.
Chrissobolis S; Sobey CG
Stroke; 2002 Jun; 33(6):1692-7. PubMed ID: 12053013
[TBL] [Abstract][Full Text] [Related]
19. Potassium channel activators protect the N-methyl-D-aspartate-induced cerebral vascular dilation after combined hypoxia and ischemia in piglets.
Veltkamp R; Domoki F; Bari F; Busija DW
Stroke; 1998 Apr; 29(4):837-42; discussion 842-3. PubMed ID: 9550520
[TBL] [Abstract][Full Text] [Related]
20. Effect of pretreatment with atenolol and nifedipine on ZD6126-induced cardiac toxicity in rats.
Gould S; Westwood FR; Curwen JO; Ashton SE; Roberts DW; Lovick SC; Ryan AJ
J Natl Cancer Inst; 2007 Nov; 99(22):1724-8. PubMed ID: 18000220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
